Titre : 2-Cyano-acrylate d'isobutyle

2-Cyano-acrylate d'isobutyle : Questions médicales fréquentes

Termes MeSH sélectionnés :

Informatics
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "2-Cyano-acrylate d'isobutyle : Questions médicales les plus fréquentes", "headline": "2-Cyano-acrylate d'isobutyle : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les 2-Cyano-acrylate d'isobutyle : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-15", "dateModified": "2025-04-09", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "2-Cyano-acrylate d'isobutyle" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Enbucrilate", "url": "https://questionsmedicales.fr/mesh/D004659", "about": { "@type": "MedicalCondition", "name": "Enbucrilate", "code": { "@type": "MedicalCode", "code": "D004659", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "J01.637.051.919.367.341" } } }, "about": { "@type": "MedicalCondition", "name": "2-Cyano-acrylate d'isobutyle", "alternateName": "Bucrylate", "code": { "@type": "MedicalCode", "code": "D002015", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Michael Schultheiß", "url": "https://questionsmedicales.fr/author/Michael%20Schulthei%C3%9F", "affiliation": { "@type": "Organization", "name": "Department of Gastroenterology, University Hospital of Freiburg, Hugstetter Str. 55, 79106, Freiburg, Germany." } }, { "@type": "Person", "name": "Max Giesler", "url": "https://questionsmedicales.fr/author/Max%20Giesler", "affiliation": { "@type": "Organization", "name": "Department of Gastroenterology, University Hospital of Freiburg, Hugstetter Str. 55, 79106, Freiburg, Germany." } }, { "@type": "Person", "name": "Lars Maruschke", "url": "https://questionsmedicales.fr/author/Lars%20Maruschke", "affiliation": { "@type": "Organization", "name": "Department of Radiology, University Hospital of Freiburg, Hugstetter Str. 55, 79106, Freiburg, Germany." } }, { "@type": "Person", "name": "Arthur Schmidt", "url": "https://questionsmedicales.fr/author/Arthur%20Schmidt", "affiliation": { "@type": "Organization", "name": "Department of Gastroenterology, University Hospital of Freiburg, Hugstetter Str. 55, 79106, Freiburg, Germany." } }, { "@type": "Person", "name": "Lukas Sturm", "url": "https://questionsmedicales.fr/author/Lukas%20Sturm", "affiliation": { "@type": "Organization", "name": "Department of Gastroenterology, University Hospital of Freiburg, Hugstetter Str. 55, 79106, Freiburg, Germany." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Lessons Learned in Change Management in Deploying Novel Informatics Solutions: Experience Implementing a Point-of-Care Patient Photography System with Radiography.", "datePublished": "2023-06-15", "url": "https://questionsmedicales.fr/article/37322308", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s10278-023-00796-y" } }, { "@type": "ScholarlyArticle", "name": "Real-world implementation evaluation of an electronic health record-integrated consumer informatics tool that collects patient-generated contextual data.", "datePublished": "2022-06-11", "url": "https://questionsmedicales.fr/article/35714549", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.ijmedinf.2022.104810" } }, { "@type": "ScholarlyArticle", "name": "The discovery of the natural compound Boeravinone-C as a potential antiobesity drug candidate targeting pancreatic lipase using chemo-informatics-based approaches.", "datePublished": "2023-07-31", "url": "https://questionsmedicales.fr/article/37715427", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.14715/cmb/2023.69.7.10" } }, { "@type": "ScholarlyArticle", "name": "Metabolomics Peak Analysis Computational Tool (MPACT): An Advanced Informatics Tool for Metabolomics and Data Visualization of Molecules from Complex Biological Samples.", "datePublished": "2023-06-01", "url": "https://questionsmedicales.fr/article/37260127", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1021/acs.analchem.2c04632" } }, { "@type": "ScholarlyArticle", "name": "Structural informatic study of determined and AlphaFold2 predicted molecular structures of 13 human solute carrier transporters and their water-soluble QTY variants.", "datePublished": "2022-11-22", "url": "https://questionsmedicales.fr/article/36418372", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41598-022-23764-y" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Technologie, industrie et agriculture", "item": "https://questionsmedicales.fr/mesh/D013676" }, { "@type": "ListItem", "position": 3, "name": "Produits manufacturés", "item": "https://questionsmedicales.fr/mesh/D008420" }, { "@type": "ListItem", "position": 4, "name": "Matériaux biomédicaux et dentaires", "item": "https://questionsmedicales.fr/mesh/D001697" }, { "@type": "ListItem", "position": 5, "name": "Adhésifs tissulaires", "item": "https://questionsmedicales.fr/mesh/D014014" }, { "@type": "ListItem", "position": 6, "name": "Cyanoacrylates", "item": "https://questionsmedicales.fr/mesh/D003487" }, { "@type": "ListItem", "position": 7, "name": "Enbucrilate", "item": "https://questionsmedicales.fr/mesh/D004659" }, { "@type": "ListItem", "position": 8, "name": "2-Cyano-acrylate d'isobutyle", "item": "https://questionsmedicales.fr/mesh/D002015" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : 2-Cyano-acrylate d'isobutyle - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur 2-Cyano-acrylate d'isobutyle", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-17", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur 2-Cyano-acrylate d'isobutyle", "description": "Comment le Bucrylate est-il utilisé en diagnostic ?\nQuels tests sont nécessaires avant d'utiliser le Bucrylate ?", "url": "https://questionsmedicales.fr/mesh/D002015?mesh_terms=Informatics&page=5#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur 2-Cyano-acrylate d'isobutyle", "description": "Quels symptômes peuvent survenir après l'application de Bucrylate ?\nLe Bucrylate peut-il provoquer des douleurs ?", "url": "https://questionsmedicales.fr/mesh/D002015?mesh_terms=Informatics&page=5#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur 2-Cyano-acrylate d'isobutyle", "description": "Comment prévenir les réactions allergiques au Bucrylate ?\nQuelles précautions doivent être prises lors de l'utilisation du Bucrylate ?", "url": "https://questionsmedicales.fr/mesh/D002015?mesh_terms=Informatics&page=5#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur 2-Cyano-acrylate d'isobutyle", "description": "Le Bucrylate est-il utilisé pour traiter des infections ?\nComment le Bucrylate favorise-t-il la cicatrisation ?", "url": "https://questionsmedicales.fr/mesh/D002015?mesh_terms=Informatics&page=5#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur 2-Cyano-acrylate d'isobutyle", "description": "Quelles complications peuvent survenir avec le Bucrylate ?\nLe Bucrylate peut-il causer des réactions systémiques ?", "url": "https://questionsmedicales.fr/mesh/D002015?mesh_terms=Informatics&page=5#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur 2-Cyano-acrylate d'isobutyle", "description": "Qui est à risque d'allergie au Bucrylate ?\nLes enfants peuvent-ils utiliser le Bucrylate ?", "url": "https://questionsmedicales.fr/mesh/D002015?mesh_terms=Informatics&page=5#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment le Bucrylate est-il utilisé en diagnostic ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Il n'est pas utilisé pour le diagnostic, mais pour la fermeture des plaies." } }, { "@type": "Question", "name": "Quels tests sont nécessaires avant d'utiliser le Bucrylate ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Aucun test spécifique n'est requis, mais l'historique allergique doit être vérifié." } }, { "@type": "Question", "name": "Quels symptômes peuvent survenir après l'application de Bucrylate ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des rougeurs, démangeaisons ou gonflements peuvent apparaître au site d'application." } }, { "@type": "Question", "name": "Le Bucrylate peut-il provoquer des douleurs ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des douleurs légères peuvent survenir, mais elles sont généralement temporaires." } }, { "@type": "Question", "name": "Comment prévenir les réactions allergiques au Bucrylate ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Évaluer l'historique allergique et effectuer un test cutané si nécessaire." } }, { "@type": "Question", "name": "Quelles précautions doivent être prises lors de l'utilisation du Bucrylate ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Éviter le contact avec les yeux et les muqueuses, et utiliser dans un environnement stérile." } }, { "@type": "Question", "name": "Le Bucrylate est-il utilisé pour traiter des infections ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Non, il est utilisé pour la fermeture des plaies, pas pour traiter les infections." } }, { "@type": "Question", "name": "Comment le Bucrylate favorise-t-il la cicatrisation ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Il forme une barrière protectrice qui aide à maintenir l'humidité et à réduire l'infection." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec le Bucrylate ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des infections, des réactions allergiques ou des cicatrices anormales peuvent survenir." } }, { "@type": "Question", "name": "Le Bucrylate peut-il causer des réactions systémiques ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des réactions systémiques sont rares, mais possibles en cas d'allergie sévère." } }, { "@type": "Question", "name": "Qui est à risque d'allergie au Bucrylate ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes ayant des antécédents d'allergies aux adhésifs ou aux cyanoacrylates." } }, { "@type": "Question", "name": "Les enfants peuvent-ils utiliser le Bucrylate ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, mais avec prudence et sous supervision médicale en raison de leur peau sensible." } } ] } ] }

Sources (443 au total)

Lessons Learned in Change Management in Deploying Novel Informatics Solutions: Experience Implementing a Point-of-Care Patient Photography System with Radiography.

We describe implementation of a point-of-care system for simultaneous acquisition of patient photographs along with portable radiographs at a large academic hospital. During the implementation process...

Real-world implementation evaluation of an electronic health record-integrated consumer informatics tool that collects patient-generated contextual data.

Use the RE-AIM framework to examine the implementation of a patient contextual data (PCD) Tool designed to share patients' needs, values, and preferences with care teams ahead of clinical encounters.... Observational study that follows initial PCD Tool scaling across primary care at a Midwestern academic health network. Program invitations, enrollment, patient submissions, and clinician views were tr... Of 58,874 patients who could be contacted by email, 9,183 (15.6%) became PCD Tool users. Overall, 76% of primary care providers had patients who used the PCD Tool. Older age, female gender, non-minori... The intervention mainly reached non-minority patients and patients who used more health services. Given the requirement for an email address on file, some patients may have been underrepresented. Over... Healthcare organizations must implement effective methods to increase the reach, adoption, implementation, and maintenance of PCD tools across all patient populations. Assisting people, particularly r...

Metabolomics Peak Analysis Computational Tool (MPACT): An Advanced Informatics Tool for Metabolomics and Data Visualization of Molecules from Complex Biological Samples.

Untargeted metabolomics is a powerful tool for investigating chemistry of complex biological systems, but its utility is compromised by the presence of uninformative features and the limited efficienc...

Development of a Natural Language Processing System for Extracting Rheumatoid Arthritis Outcomes From Clinical Notes Using the National Rheumatology Informatics System for Effectiveness Registry.

To accelerate the use of outcome measures in rheumatology, we developed and evaluated a natural language processing (NLP) pipeline for extracting these measures from free-text outpatient rheumatology ... We included all patients in RISE (2015-2018). The NLP pipeline extracted scores corresponding to 8 measures of rheumatoid arthritis (RA) disease activity (DA) and functional status (FS) documented in ... We processed over 34 million notes from 854,628 patients, 158 practices, and 24 electronic health record (EHR) systems from RISE. Manual chart review revealed a sensitivity, positive predictive value ... We developed an NLP pipeline to extract RA outcome measures from a national registry of notes from multiple EHR systems and found it to have good internal and external validity. This pipeline can faci...

Cell Therapy Informatics: Updates on the Integration of HCT/IEC Functionalities into an Electronic Medical Record System in the US to Promote Efficiency, Patient Safety, Research, and Data Interoperability.

The use of electronic health/medical record (EMR) systems has streamlined medical practice and improved efficiency of clinical care in recent years. However, EMR systems are not generally well designe...

Influence of Multimorbidity on New Treatment Initiation and Achieving Target Disease Activity Thresholds in Active Rheumatoid Arthritis: A Cohort Study Using the Rheumatology Informatics System for Effectiveness Registry.

To determine whether multimorbidity is associated with treatment changes and achieving target disease activity thresholds in patients with active rheumatoid arthritis (RA).... We conducted a retrospective cohort study of adults with active RA within the Rheumatology Informatics System for Effectiveness (RISE) registry. Multimorbidity was measured using RxRisk, a medication-... We identified 15,626 patients using the Routine Assessment of Patient Index Data 3 (RAPID3) cohort and 5,733 patients using the Clinical Disease Activity Index (CDAI) cohort. All patients had active R... These findings from a large, real-world registry illustrate the potential impact of multimorbidity on treatment response and indicate that a more holistic management approach targeting multimorbidity ...

Rapid identification of chemical components in Zhizi Baipi decoction by ultra-performance liquid chromatography quadrupole time-of-flight mass spectrometry coupled with a novel informatics UNIFI platform.

Zhizi Baipi decoction is a classic traditional Chinese medicine formula for the treatment of jaundice and various liver diseases. The chemical components of Zhizi baipi decoction were not clear result...

Operational Ontology for Oncology (O3): A Professional Society-Based, Multistakeholder, Consensus-Driven Informatics Standard Supporting Clinical and Research Use of Real-World Data From Patients Treated for Cancer.

The ongoing lack of data standardization severely undermines the potential for automated learning from the vast amount of information routinely archived in electronic health records (EHRs), radiation ... The American Association of Physicists in Medicine's Big Data Science Committee was initiated in July 2019 to explore common ground from the stakeholders' collective experience of issues that typicall... We developed the Operational Ontology for Oncology (O3), which identified 42 key elements, 359 attributes, 144 value sets, and 155 relationships ranked in relative importance of clinical significance,... O3 is designed to extend and interoperate with existing global infrastructure and data science standards. The implementation of these recommendations will lower the barriers for aggregation of informa...